RecruitingNCT06640764

Multicentre SMS Study - FR

Étude Prospective, Multicentrique, Non contrôlée, Non randomisée, Ouverte évaluant la Performance et la stabilité de l'Implant fémoral Non cimenté SMS

Sponsor

Medacta International SA

Enrollment

260 participants

Start Date

Sep 1, 2024

Study Type

OBSERVATIONAL

Conditions

hip osteoarthritis Dysplasia of Hip Joint Traumatic Arthritis of Hip Avascular Necrosis of Femur Head

Summary

Prospective, multicentre, non controled, non randomised, clinical study to assess the performance and the stability of SMS femoral stem

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Total Hip Arthroplasty for people with avascular necrosis of femur head, dysplasia of hip joint, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETotal Hip Arthroplasty

Total Hip Arthroplasty with SMS Femoral Stem (Medacta)

Locations(1)

Clinique de l'Union

Saint-Jean, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06640764

Related Trials

Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults

NCT073309991 location

PENG Block and Delirium After Hip Arthroplasty

NCT074494681 location